0001437749-21-002824.txt : 20210212 0001437749-21-002824.hdr.sgml : 20210212 20210212164725 ACCESSION NUMBER: 0001437749-21-002824 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 GROUP MEMBERS: DUGABOY INVESTMENT TRUST GROUP MEMBERS: JAMES D. DONDERO GROUP MEMBERS: NEXPOINT ADVISORS, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81821 FILM NUMBER: 21628737 BUSINESS ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 807-6600 MAIL ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. CENTRAL INDEX KEY: 0001469877 IRS NUMBER: 264245035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 972-628-4100 MAIL ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: Pyxis Capital, L.P. /DE DATE OF NAME CHANGE: 20120406 FORMER COMPANY: FORMER CONFORMED NAME: Highland Funds Asset Management, L.P. DATE OF NAME CHANGE: 20090806 SC 13G 1 highfund20210211_sc13g.htm SCHEDULE 13G highfund20210211_sc13g.htm

 

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

 

Paratek Pharmaceuticals, Inc. 

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

 

699374302

(CUSIP Number)

 

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☒     Rule 13d-1(b)

☐     Rule 13d-1(c)

☐     Rule 13d-1(d)

 

 

 

 

CUSIP No. 699374302

 

13G

Page 2 of 10

 

1

NAME OF REPORTING PERSONS

 

Highland Capital Management Fund Advisors, L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐
(b)  ☐

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

5

SOLE VOTING POWER

 

0

SHARES

BENEFICIALLY

OWNED BY

6

SHARED VOTING POWER

 

90,020

EACH

REPORTING
PERSON WITH

7

SOLE DISPOSITIVE POWER

 

0

 

8

SHARED DISPOSITIVE POWER

 

90,020

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

90,020

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES


11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.2%

12

TYPE OF REPORTING PERSON*

 

IA, PN

 

 

 

 

CUSIP No. 699374302

 

13G

Page 3 of 10

 

1

NAME OF REPORTING PERSONS

 

NexPoint Advisors, L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a)  ☐
(b)  ☐

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

5

SOLE VOTING POWER

 

0

SHARES
BENEFICIALLY
OWNED BY

6

SHARED VOTING POWER

 

50,000

EACH
REPORTING
PERSON WITH

7

SOLE DISPOSITIVE POWER

 

0

 

8

SHARED DISPOSITIVE POWER

 

50,000

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

50,000

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES


11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.1%

12

TYPE OF REPORTING PERSON*

 

IA, PN

 

 

 

CUSIP No. 699374302

 

13G

Page 4 of 10

 

1

NAME OF REPORTING PERSONS

 

James D. Dondero

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐
(b)  ☐

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF

5

SOLE VOTING POWER

 

0

SHARES
BENEFICIALLY
OWNED BY

6

SHARED VOTING POWER

 

2,301,555

EACH
REPORTING
PERSON WITH

7

SOLE DISPOSITIVE POWER

 

0

 

8

SHARED DISPOSITIVE POWER

 

2,301,555

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,301,555

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 


11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

5.0%

12

TYPE OF REPORTING PERSON

 

HC, IN

 

 

 

 

CUSIP No. 699374302

 

13G

Page 5 of 10

 

1

NAME OF REPORTING PERSONS

 

The Dugaboy Investment Trust

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐
(b)  ☐

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

5

SOLE VOTING POWER

 

2,161,535

SHARES
BENEFICIALLY
OWNED BY

6

SHARED VOTING POWER

 

0

EACH
REPORTING
PERSON WITH

7

SOLE DISPOSITIVE POWER

 

2,161,535

 

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,161,535

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 


11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

4.74%

12

TYPE OF REPORTING PERSON

OO

 

 

 

 

 

CUSIP No. 699374302

 

13G

Page 6 of 10

 

 

SCHEDULE 13G

 

This Schedule 13G (this “Filing”) is being filed on behalf of Highland Capital Management Fund Advisors, L.P., a Delaware limited partnership (“HCMFA”), NexPoint Advisors, L.P., a Delaware limited partnership (“NexPoint”), The Dugaboy Investment Trust, a Delaware Trust (the “Trust”), and James D. Dondero (collectively, the “Reporting Persons”).

 

Item 1(a) Name of Issuer.
   
  Paratek Pharmaceuticals, Inc.
   

Item 1(b)

Address of Issuer’s Principal Executive Offices.

   
 

75 Park Plaza

Boston, Massachusetts 02116

   
Item 2(a) Name of Person Filing.

 

 

(1)

Highland Capital Management Fund Advisors, L.P.

 

(2)

NexPoint Advisors, Inc.

 

(3)

The Dugaboy Investment Trust

 

(4)

James D. Dondero

 

Item 2(b)

Address of Principal Business Office, or, if none, Residence.

   
  For all Filers:
   
 

300 Crescent Court, Suite 700

Dallas, Texas 75201

   
Item 2(c)  Citizenship or Place of Organization.

  

 

(1)

Highland Capital Management Fund Advisors, L.P. is a Delaware limited partnership

 

(2)

NexPoint Advisors, L.P. is a Delaware limited partnership

 

(3)

James D. Dondero is a United States citizen

 

(4)

The Dugaboy Investment Trust is a Delaware trust

 

Item 2(d)

Title of Class of Securities.

   
  Common Stock, par value $0.001 per share

 

 

 

CUSIP No. 699374302

 

13G

Page 7 of 10

 

Item 2(e)

CUSIP Number.

   
  699374302
   
Item 3  Reporting Person.

 

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

 

(a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
     
(b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
     
(c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
     
(d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
     
(e) An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
     
(f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
     
(g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
     
(h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
     
(i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
     
(j)   Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Item 4

Ownership.

 

 

(a)

Amount beneficially owned:

     
   

Highland Capital Management Fund Advisors, L.P.: 90,020

NexPoint Advisors, L.P.: 50,000

The Dugaboy Investment Trust: 2,161,535

James D. Dondero: 2,301,555

 

 

 

CUSIP No. 699374302

 

13G

Page 8 of 10

 

 

 

(b)

Percent of Class:

     
   

Highland Capital Management Fund Advisors, L.P.: 0.2%

NexPoint Advisors, L.P.: 0.1%

The Dugaboy Investment Trust: 4.74%

James D. Dondero: 5.0%

 

 

(c)

Number of shares as to which the person has:

 

 

(i)

Sole power to vote or to direct the vote:

     
   

Highland Capital Management Fund Advisors, L.P.: 0

NexPoint Advisors, L.P.: 0

The Dugaboy Investment Trust: 2,161,535

James D. Dondero: 0

 

 

(ii)

Shared power to vote or direct the vote:

     
   

Highland Capital Management Fund Advisors, L.P.: 90,020

NexPoint Advisors, L.P.: 50,000

The Dugaboy Investment Trust: 0

James D. Dondero: 2,301,555

 

 

(iii)

Sole power to dispose or to direct the disposition of:

     
   

Highland Capital Management Fund Advisors, L.P.: 0

NexPoint Advisors, L.P.: 0

The Dugaboy Investment Trust: 2,161,535

James D. Dondero: 0

 

 

(iv)

Shared power to dispose or to direct the disposition of:

     
   

Highland Capital Management Fund Advisors, L.P.: 90,020

NexPoint Advisors, L.P.: 50,000

The Dugaboy Investment Trust: 0

James D. Dondero: 2,301,555

 

 

 

CUSIP No. 699374302

 

13G

Page 9 of 10

 

 

Item 5

Ownership of Five Percent or Less of a Class.

   
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ]

 

Item 6

Ownership of More Than Five Percent on Behalf of Another Person.

   
  Inapplicable.

 

Item 7

Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.

   
  Inapplicable.

 

Item 8

Identification and Classification of Members of the Group.

   
  Inapplicable.

 

Item 9

Notice of Dissolution of Group.

   
  Inapplicable.

 

Item 10

Certification.

   
  By signing below each of the Reporting Persons certifies that, to the best of such person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Exhibits

Exhibit 99-1

   
  Joint Filing Agreement, dated February 12, 2021, by and among HCMFA, NexPoint, the Trust and James D. Dondero.

 

 

 

 

CUSIP No. 699374302

 

13G

Page 10 of 10

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Date: February 12, 2021


HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P.

 

By:     Strand Advisors XVI, Inc., its general partner

 

By:      /s/ James D. Dondero                              

Name: James D. Dondero

Title: Sole Member

 

 

NEXPOINT ADVISORS, L.P.

 

By: NexPoint Advisors GP, LLC, its general partner

 

By:      /s/ James D. Dondero                               

Name: James D. Dondero

Title: Sole Member

 

 

THE DUGABOY INVESTMENT TRUST

 

By:      /s/ Nancy Dondero                                         

Name: Nancy Dondero

Title: Trustee

 

 

/s/ James D. Dondero                                                

James D. Dondero

 

 
EX-99.1 2 ex_226104.htm EXHIBIT 99.1 ex_226104.htm

 

EXHIBIT 99-1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.001 per share, of Paratek Pharmaceuticals, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

 

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

 

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

 

 

[Signature Page Follows]

 

 

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of February 12, 2021.

 

HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P.

 

By:     Strand Advisors, Inc., its general partner

 

By:      /s/ James D. Dondero                                 

Name: James D. Dondero

Title: Secretary

 

 

NEXPOINT ADVISORS, L.P.

 

By: NexPoint Advisors GP, LLC, its general partner

 

By:      /s/ James D. Dondero                                    

Name: James D. Dondero

Title: Sole Member

 

 

THE DUGABOY INVESTMENT TRUST

 

By:      /s/ Nancy Dondero                                              

Name: Nancy Dondero

Title: Trustee

 

 

/s/ James D. Dondero                                                      

James D. Dondero